What question did this study set out to answer?

To evaluate the limitations of existing treatments for Chagas disease and review emerging biochemical targets against Trypanosoma cruzi, with an emphasis on sterol biosynthesis inhibitors.

April 1, 2006Anti-Infective Agents

Advances in Chagas Disease Chemotherapy

View Full Paper

Ask AI

Bookmark

Authors

PGPaulo Marcos da Matta GuedesUniversidade Federal do Rio Grande do Norte JFJuliana Lopes Rangel FiettoUniversidade Federal de Viçosa MLMarta de LanaUniversidade Federal de Ouro Preto

Discussion

Member takes

Implication

Review highlights sterol biosynthesis inhibitors and novel metabolic targets for Trypanosoma cruzi, suggesting improved therapeutic strategies for chronic Chagas disease.

Key Points

To evaluate the limitations of existing treatments for Chagas disease and review emerging biochemical targets against Trypanosoma cruzi, with an emphasis on sterol biosynthesis inhibitors.
Evaluated the clinical efficacy, toxicity profiles, and stage-specific limitations of benznidazole and nifurtimox in acute and chronic infections.
Reviewed preclinical in vivo and in vitro assessments of sterol biosynthesis inhibitors and alternate metabolic pathway inhibitors across murine and canine models.
Standard drugs benznidazole and nifurtimox show very low activity in preventing chronic disease progression and produce significant toxic side effects.
Sterol biosynthesis inhibitors exhibit potent suppressive and curative trypanocidal activity in experimental animal models of both acute and chronic infection.
Identified alternative viable therapeutic targets, including antiproliferative lysophospholipid analogs, cysteine proteases, purine salvage mechanisms, and inositol metabolism.

Cite This Study

Guedes et al. (2006) studied this question.

synapsesocial.com/papers/6a95877f7ee17f80122cbfc4 https://doi.org/10.2174/187152106776359020

View Full Paper

Ask AI

Bookmark

Implication

Review highlights sterol biosynthesis inhibitors and novel metabolic targets for Trypanosoma cruzi, suggesting improved therapeutic strategies for chronic Chagas disease.

Advances in Chagas Disease Chemotherapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Advances in Chagas Disease Chemotherapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider